DuPont 2015 Annual Report Download - page 58

Download and view the complete annual report

Please find page 58 of the 2015 DuPont annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

Part IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES, continued
57
10.14* Separation Agreement dated October 5, 2015, by and between E.I. du Pont Nemours and Company and Ellen J.
Kullman (incorporated by reference to Exhibit 10.1 to the company's Current Report on Form 8-K (Commission file
number 1-815) dated October 5, 2015).
10.15* Form of 2015 Award Terms under the Company's Equity and Incentive Plan (incorporated by reference to Exhibit
10.15 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March
31, 2015).
10.16* Letter Agreement dated January 4, 2016, by and between the Company and Mr. James C. Borel (incorporated by
reference to Exhibit 10.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated
January 22, 2016).
10.17** Separation Agreement by and between the Company and The Chemours Company (incorporated by reference to
Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
10.18 Tax Matters Agreement by and between the Company and The Chemours Company (incorporated by reference to
Exhibit 2.2 to the company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
10.19** Agreement and Plan of Merger by and between the Company and The Dow Chemical Company, dated as of December
11, 2015 (incorporated by reference to Exhibit 2.1 to the company's Current Report on Form 8-K (Commission file
number 1-815) dated December 11, 2015).
10.20** Master Repurchase Agreement with Cooperatieve Rabobank, U.A. (New York Branch) and The Bank of Tokyo
Mitsubishi UFJ Ltd. (New York Branch) dated as of February 3, 2016.
10.21** Master Framework Agreement with Cooperatieve Rabobank, U.A. (New York Branch) and The Bank of Tokyo
Mitsubishi UFJ Ltd. (New York Branch) dated as of February 3, 2016.
12 Computation of Ratio of Earnings to Fixed Charges.
21 Subsidiaries of the Registrant.
23 Consent of Independent Registered Public Accounting Firm.
31.1 Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Executive Officer.
31.2 Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Financial Officer.
32.1
Section 1350 Certification of the company’s Principal Executive Officer. The information contained in this
Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in
any registration statement filed by the registrant under the Securities Act of 1933, as amended.
32.2
Section 1350 Certification of the company’s Principal Financial Officer. The information contained in this
Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in
any registration statement filed by the registrant under the Securities Act of 1933, as amended.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
*Management contract or compensatory plan or arrangement.
** DuPont hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the U.S. Securities and Exchange
Commission upon request.